Introduction
============

Autoimmune inner ear disease (AIED) is one of the few reversible causes of rapidly progressive, bilateral sensorineural hearing loss (SNHL) over a period ranging from weeks to months ([@b1-etm-0-0-6479]). It has been reported that AIED has a predilection to occur in young adults, but variable prevalence is also observed during childhood (4--30%) ([@b2-etm-0-0-6479],[@b3-etm-0-0-6479]). SNHL is frequently accompanied by tinnitus, persistent vertigo and increased depression, which disrupt activities and personal relationships by severely affecting the quality of life ([@b4-etm-0-0-6479],[@b5-etm-0-0-6479]).

Currently, corticosteroids are a cornerstone in the treatment of AIED; however, a successful reduction of symptoms and the preservation of hearing can only be achieved in \~60% of patients following timely corticosteroid administration ([@b6-etm-0-0-6479]). In addition, prolonged use of high-dose corticosteroids (\>4 weeks) carries risk of serious adverse events, including hyperglycemia and weight gain ([@b7-etm-0-0-6479]). In steroid-dependent patients, hearing immediately worsens if the dose declines ([@b8-etm-0-0-6479]). The development of novel treatment strategies is crucial for the effective management of the disease.

Although the pathogenesis is not fully understood, cell- and/or humoral-mediated immune injuries serve important roles in the development of AIED ([@b9-etm-0-0-6479]). When a foreign antigen enters the inner ear, it is first processed by immunocompetent cells present in and around the endolymphatic sac (ES) ([@b10-etm-0-0-6479]). These immunocompetent cells secrete various cytokines, including interleukin (IL)-1β and tumor necrosis factor (TNF)-α, which recruit inflammatory cells from the systemic circulation to the cochlea, further amplifying the immune response and deteriorating inner ear damages ([@b9-etm-0-0-6479],[@b11-etm-0-0-6479],[@b12-etm-0-0-6479]). Several TNF-α ([@b13-etm-0-0-6479]) or IL-1β ([@b14-etm-0-0-6479]) antagonists have been suggested as potential agents for treating patients with AIED with no response to corticosteroid treatment. Alternative medicines for AIED remain rare and further investigations into the crucial genes for inflammatory response in ES are necessary.

Previously, studies analyzed the global gene expression profile of the ES in rats ([@b15-etm-0-0-6479]) and humans ([@b16-etm-0-0-6479],[@b17-etm-0-0-6479]). In comparison with adjacent dura tissues, several inflammatory response-associated genes were identified, including macrophage migration inhibitory factor, small inducible cytokine subfamily e, member 1, the C-C chemokine ligand (Ccl)21b (serine) and toll-like receptor (Tlr)7 ([@b15-etm-0-0-6479],[@b16-etm-0-0-6479]). In the current study, the microarray data from Friis *et al* ([@b15-etm-0-0-6479]) was further analyzed in order to identify inflammatory response-associated genes in the ES by constructing a protein-protein interaction (PPI) network, through module analysis and by common gene screening.

Materials and methods
=====================

### Microarray data

The microarray data were obtained from the European Bioinformatics Institute database (ebi.ac.uk) with the accession number E-MEXP-3022 ([@b15-etm-0-0-6479]). The dataset contained three biological replicates of ES plus dura tissues and three biological replicates of pure dura tissues obtained from 10-week-old Lewis inbred rats.

### Data normalization and identification of differentially expressed genes (DEG)

Raw data were downloaded from the A-AFFY-43-Affymetrix GeneChip Rat Genome 230 2.0 (Rat230_2) platform (ebi.ac.uk/arrayexpress/arrays/A-AFFY-43/?ref=E-MEXP-3022) and preprocessed to normalize and generate probe-level expression data using the Robust Multichip Average algorithm ([@b18-etm-0-0-6479]) as implemented in the 'affy' package in Bioconductor R (<http://www.bioconductor.org/packages/release/bioc/html/affy.html>). When multiple probe IDs were matched to the same gene symbol, the average value of expression was determined and the probe ID closest to this value was selected to represent the gene symbol.

DEGs between ES plus dura tissues and pure dura tissues were identified using the Linear Model for Microarray data t-test method ([@b19-etm-0-0-6479]) from the Bioconductor R package (<http://www.bioconductor.org/packages/release/bioc/html/limma.html>). Genes were considered differentially expressed at P\<0.05 and \|logFC(fold change)\|\>1.

To determine whether DEGs have the ability to differentiate between ES plus dura tissues and pure dura tissues, clustering analysis ([@b20-etm-0-0-6479]) was performed to generate a heat map using the ComplexHeatmap R package (<https://github.com/jokergoo/ComplexHeatmap>).

### PPI network construction

DEGs were mapped into the Search Tool for the Retrieval of Interacting Genes/Proteins 10.0 database (<http://stringdb.org>) ([@b21-etm-0-0-6479]) to obtain PPI pairs. Pairs with PPI score ≥0.4 were retained to construct the PPI network using Cytoscape software 2.8 ([www.cytoscape.org](www.cytoscape.org)) ([@b22-etm-0-0-6479]).

Crucial nodes within the PPI network were identified by calculating three topological properties using the CytoNCA plugin (version 2.1.6, parameter: Without weight) in the Cytoscape software (<http://apps.cytoscape.org/apps/cytonca>) ([@b23-etm-0-0-6479]), including the degree \[the number of interactions per node (protein)\] ([@b24-etm-0-0-6479]), the betweenness (the number of shortest paths that pass through each node) ([@b25-etm-0-0-6479]) and subgraph centrality (the weighted sum of all closed walks originating from each node) ([@b26-etm-0-0-6479]).

Functionally associated and densely interconnected modules were extracted from the PPI network using Clustering with Overlapping Neighborhood Expansion (ClusterONE version 1.0; <ftp://ftp.mshri.on.ca/pub/BIND/Tools/MCODE>) in the Cytoscape software ([@b27-etm-0-0-6479]). Significant submodules were identified using P\<0.01 and nodes ≥6.

### Function enrichment analysis

To explain the underlying functions of DEGs, Gene ontology (GO), including the terms of molecular function (MF), biological process (BP) and cellular component (CC), and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) 6.8 online tool (<http://david.abcc.ncifcrf.gov>) ([@b28-etm-0-0-6479]) based on hypergeometric tests. Counts ≥2 and P\<0.05 were set as cut-off values.

### Comparison with previous literature

To further confirm the key genes in ES for AIED, the results were also compared with previous studies by Møller *et al* ([@b16-etm-0-0-6479],[@b17-etm-0-0-6479]), which investigated the gene expression profile of ES in humans.

Results
=======

### Identification of DEGs

A total of 612 genes were identified as DEGs between ES plus dura tissues and pure dura tissues based on the set threshold (P\<0.05 and \|logFC\|\>1), including 396 up- and 216 downregulated genes ([Table I](#tI-etm-0-0-6479){ref-type="table"}). Identified DEGs may allow to distinguish ES plus dura tissues from pure dura tissues according to the heat map presented in [Fig. 1](#f1-etm-0-0-6479){ref-type="fig"}.

### Function enrichment analysis of DEGs

GO enrichment analysis was performed for all DEGs to reveal underlying functions. As a result, 116 (59 BP, 35 CC and 22 MF) GO terms were enriched for upregulated DEGs, including GO:0007155-cell adhesion, with α5-integrin (Itga1) and secreted phosphoprotein 1 (Spp1); GO:0031295-T cell co-stimulation, with Ccl21 and Ccl19; and GO:0070555-response to IL-1, with Ccl21 and Ccl19 ([Table II](#tII-etm-0-0-6479){ref-type="table"}). For downregulated DEGs, 77 (including 48 BP, 11 CC, and 18 MF) GO terms were enriched. In line with the upregulated DEGs, the majority of downregulated DEGs was associated with GO:0007155-cell adhesion, with transforming growth factor (Tgf)-βi; GO:0002224-toll-like receptor signaling pathway, with Tlr2, Tlr7 and Tlr8; and GO:0042346-positive regulation of nuclear factor (NF)-κB import into the nucleus, with Tlr2 and Tlr7 ([Table II](#tII-etm-0-0-6479){ref-type="table"}).

Pathway analyses were also performed using DAVID software. Upregulated DEGs were predicted to participate in six pathways, including rno04530: Tight junction, with claudin (Cldn)-4; rno04512: Extracellular matrix (ECM)-receptor interaction, with Itga1 and Spp1; and rno04670: Leukocyte transendothelial migration, with Cldn4 ([Table III](#tIII-etm-0-0-6479){ref-type="table"}). Downregulated DEGs were enriched in seven pathways, including inflammation-associated diseases, rno05144: Malaria, with Tgf-β3 and Tlr2 ([Table III](#tIII-etm-0-0-6479){ref-type="table"}).

### PPI network construction

Following the mapping of DEGs into protein interactions pairs, a PPI network was constructed, including 338 nodes and 777 edges (interaction relationships; [Fig. 2](#f2-etm-0-0-6479){ref-type="fig"}). Key nodes in the PPI network were screened by calculating the degree, betweenness and subgraph centrality. Ripk4, Dpyd, Actg2, Fos, Pcsk5, Aldh1a1, Calb1, Pcsk6, Myo5c, Gad1 and Eno3 were in the top 20 genes of the three topological characteristics, but were not determined to be enriched in adhesion or immune pathways. Itga1 and Spp1 were enriched in adhesion or immune pathways as described above, they were also found to be crucial according to their degree and/or betweenness centrality ([Table IV](#tIV-etm-0-0-6479){ref-type="table"}).

Following ClusterONE analysis, 5 significant submodules were created ([Fig. 3](#f3-etm-0-0-6479){ref-type="fig"}). Function enrichment analysis revealed that the genes participating in module 1 were closely associated with inflammation, including Ccl21 and Ccl19, whereas the genes in module 2 and 5 were significantly enriched in cell adhesion pathways, including Cldn4 ([Fig. 4](#f4-etm-0-0-6479){ref-type="fig"}). In module 3, only one GO term, GO:0005096-GTPase activator activity, was enriched and module 3 is not presented in [Fig. 4](#f4-etm-0-0-6479){ref-type="fig"}.

### Identification of common genes in rats and humans by literature comparison

Møller *et al* ([@b16-etm-0-0-6479]) performed a study to investigate gene expression of the human ES using adjacent dura mater as the control. The authors identified that ES was a significant immunological entity within the inner ear. To screen for immune response-associated genes in the ES, the DEGs from rats from the current study were compared with human DEGs, including Tlr1, Tlr2, Tlr3, Tlr4, Tlr7, Fc fragment of IgA and IgM receptor, C-C chemokine receptor 7, C-X-C chemokine (CXC) ligand 17, CXC receptor 3, α-interferon, IL-17, β-defensins, lactotransferrin precursor, lactoperoxidase (Lpo), perforin 1, histatin, granzyme (Gzm) and mucins (Mucs). A total of 6 common genes were identified, including Tlr7, Tlr2, Tlr8, Lpo, Gzmm and Muc1 ([Table V](#tV-etm-0-0-6479){ref-type="table"}). Separate function analysis of these genes was performed. Tlr7, Tlr2, Tlr8 and Gzmm were enriched in immune or inflammatory response-associated GO terms or pathways ([Fig. 5](#f5-etm-0-0-6479){ref-type="fig"}). No enrichment was observed for Lpo and Muc1, indicating Tlr7, Tlr2, Tlr8 and Gzmm were of particular importance.

Discussion
==========

Compared with the previous study from Friis *et al* ([@b15-etm-0-0-6479]), a less restrictive threshold value \[P\<0.05 and \|logFC(fold change)\|\>1 vs. false discovery rate \<0.1\] was adopted for screening of DEGs in the ES in the current study. As a result, 619 DEGs were identified compared with 463 DEGs reported by Friis *et al* ([@b15-etm-0-0-6479]). Subsequently, DEGs were subjected to a PPI network construction, module analysis, function analysis and a comparison with the results reported by Møller *et al* ([@b16-etm-0-0-6479]), none of which was included in the work presented by Friis *et al* ([@b15-etm-0-0-6479]). The results of the current study may provide a more solid base compared with previous work and novel conclusions were obtained. In the present study, a series of inflammatory response-associated genes were screened. The hub roles of Itga1, Cd24 and Spp1 were identified by calculating three topological properties of the PPI network. Ccl21, Ccl19 and Cldn4 were demonstrated to be crucial following significant module analysis according to the corresponding threshold, which revealed they were enriched in inflammation pathways. Tlr7, Tlr2, Gzmm and Tlr8 were identified as common genes associated with inflammatory responses in rat and human ES ([@b16-etm-0-0-6479]). Abnormal expressions of the aforementioned inflammatory-associated genes may describe the underlying mechanism for the development of AIED.

Ccl21, Ccl19, Tlr7, Tlr2 and Tlr8 are known inflammatory-associated genes ([@b29-etm-0-0-6479]--[@b33-etm-0-0-6479],[@b34-etm-0-0-6479]--[@b36-etm-0-0-6479]), making their presence in ES and association with AIED plausible. It has previously been reported that Ccl19 and Ccl21 were significantly induced in several autoimmune diseases, including rheumatoid arthritis ([@b29-etm-0-0-6479]), autoimmune encephalomyelitis ([@b30-etm-0-0-6479]) and multiple sclerosis ([@b31-etm-0-0-6479]) which have been diagnosed in ≤1/3 of patients with AIED ([@b32-etm-0-0-6479],[@b33-etm-0-0-6479]). High expressions of Ccl19 and Ccl21 were demonstrated to initiate specific immune responses by co-stimulating the expansion of CD4^+^ and CD8^+^ T cells ([@b32-etm-0-0-6479]), inducing Th1 ([@b37-etm-0-0-6479]) and macrophage polarization to secrete inflammatory cytokines (including IL-8) ([@b29-etm-0-0-6479]), and mediating antigen presenting cell trafficking (including dendritic cells) ([@b38-etm-0-0-6479]). A combination of the continuous local antigenic stimulation and the maintenance of chronic inflammation ultimately lead to the development of AIED.

Tlrs are associated with the activation of the innate immune system by recognizing pathogen-associated molecular patterns ([@b39-etm-0-0-6479]). Proinflammatory effects have been described for Tlrs previously ([@b34-etm-0-0-6479]), whereas other studies implied protective effects of activated Tlr2, Tlr7 and Tlr8 in mouse models of asthma ([@b35-etm-0-0-6479],[@b36-etm-0-0-6479],[@b40-etm-0-0-6479]). Treatment with Tlr7/8 agonist, resiquimod (RSQ), was reported to reduce allergen-induced airway reactivity and inflammation ([@b35-etm-0-0-6479]). The underlying mechanism is associated with the induction of NF-E2-related factor 2 and copper/zinc superoxide dismutase ([@b35-etm-0-0-6479]). The suppressive effect of RSQ in asthma is further dependent on the induction of IL-27 and is associated with enhanced expression of the immunomodulatory molecule B7-homolog 1 on pulmonary antigen presenting cells ([@b36-etm-0-0-6479]). Pam3Cys, a Tlr2 agonist treatment, has been demonstrated to cause significant reductions of eosinophils and increase numbers of regulatory T cells (Tregs) in lung infiltrates, resulting in long-term protection against manifestation of allergic asthma ([@b40-etm-0-0-6479]). Previous studies revealed that induction of the generation of antigen specific cluster of differentiation (CD)4^+^CD25^+^forkhead box P3^+^Tregs by adipose tissue-derived stem cells significantly improved hearing function and protected inner hair cells from loss in previous AIED models ([@b41-etm-0-0-6479],[@b42-etm-0-0-6479]). The current study speculated that Tlr2 and Tlr7/8 agonist may be potential agents for the treatment of AIED, which was supported by the observed downregulation of Tlr7, Tlr2 and Tlr8 in ES.

Gzms comprise a family of serine protease (a, b, h, k and m) that is constitutively and abundantly expressed in innate effector natural killer cells to eliminate virus-infected and tumor cells to prevent inflammation ([@b43-etm-0-0-6479],[@b44-etm-0-0-6479]). Mice lacking Gzms exhibited a reduced immune tolerance and increased inflammation levels through a type I interferon-dependent pathway, leading to the development of autoimmune diseases, including diabetes ([@b43-etm-0-0-6479],[@b45-etm-0-0-6479]) and ulcerative colitis ([@b46-etm-0-0-6479]). These two autoimmune diseases were further associated with SNHL ([@b47-etm-0-0-6479],[@b48-etm-0-0-6479]). Gzmm was proposed to be downregulated in AIED, which was in accordance with the results of the current study.

The ECM is a non-cellular component in all tissues and organs and adherens junctions between cells, and are essential for the maintenance of the structural and functional integrity of organs ([@b49-etm-0-0-6479]). Disruption of ECM and adherens junctions may contribute to the destruction of the epithelial barrier and favor the interaction of leukocytes with endothelial cells, promoting the development of inflammation-associated diseases ([@b50-etm-0-0-6479]), including AIED. Cai *et al* ([@b51-etm-0-0-6479]) previously reported that the expression of ECM gene Itga5 in the basal sections of the sensory epithelium in the cochlea was positively correlated with greater hearing loss as a result to exposure to an intense noise for 2 h. Endogenous overexpression of another ECM gene, SPP1, induces Ccl5 and matrix metalloproteinase-2 activation that contributes to proinflammatory events ([@b52-etm-0-0-6479]). Lee *et al* ([@b50-etm-0-0-6479]) recently demonstrated that the level of Cldn4, coding for a tight junction protein, was increased in blood and plasma of asthmatic patients and lung tissues from the model mice, accompanied with significant increases in tight junction disruptions. A Cldn4 knockdown by small interfering RNA transfection significantly increased inflammatory cytokine expression ([@b50-etm-0-0-6479]). In accordance with these findings, SPP1, Itga1 and Cldn4 were upregulated in rats ES, suggesting these genes may be underlying targets for the treatment of AIED.

In conclusion, the present study revealed a number of important inflammatory-associated genes, including Tlr2, Tlr7, Tlr8, Gzmm, Itga1, Spp1 and Cldn4, in ES. Abnormal expression of these genes may describe the underlying mechanism for the development of AIED. Further studies with an AIED animal model are required to confirm these conclusions.
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![Function enrichment for six immune or inflammatory response-associated genes common in rats and human. GO, gene ontology; MF, molecular function; BP, biological process; KEGG, Kyoto encyclopedia of genes and genomes.](etm-16-03-2460-g04){#f5-etm-0-0-6479}

###### 

Top 20 differentially expressed genes.

  Gene            logFC   P-value
  --------------- ------- ---------
  Upregulated             
  Ambn            7.17    \<0.001
  Itgb6           3.90    \<0.001
  Foxi1           4.21    \<0.001
  Smr3b           4.89    \<0.001
  Atp6v0a4        3.87    \<0.001
  Ppp1r1b         3.81    \<0.001
  Aldh1a1         4.60    \<0.001
  Cwh43           3.57    \<0.001
  Pigr            4.70    \<0.001
  Rab17           2.23    \<0.001
  Cldn16          4.27    \<0.001
  Hoxa5           4.08    \<0.001
  Cldn4           3.87    \<0.001
  Perp            4.03    \<0.001
  Tbc1d9          3.68    \<0.001
  Pcdh10          4.20    \<0.001
  Pinlyp          3.60    \<0.001
  Coch            3.55    \<0.001
  Enpp5           3.26    \<0.001
  Fbxo2           4.00    \<0.001
  Downregulated           
  Mcpt1l1         −3.12   \<0.001
  Tpsab1          −3.64   \<0.001
  LOC102555472    −2.91   \<0.001
  Kcne4           −1.99   \<0.001
  Cpxm1           −3.67   \<0.001
  Alx1            −3.63   \<0.001
  Slc5a6          −1.63   \<0.001
  Cpxm2           −1.88   \<0.001
  Fmod            −1.54   \<0.001
  Slc6a8          −1.59   \<0.001
  Cdkn1c          −1.48   \<0.001
  RGD1305645      −1.84   \<0.001
  Efnb3           −1.40   \<0.001
  Aox1            −1.76   \<0.001
  Olfml3          −1.39   \<0.001
  Krt33b          −1.94   \<0.001
  Krt12           −3.24   \<0.001
  Elmod1          −1.73   \<0.001
  Vnn1            −1.86   \<0.001
  Mcpt10          −2.89   \<0.001

FC, fold change.

###### 

GO enrichment analysis for differentially expressed genes.

  Regulation   GO term   Specific term                                                             Count   P-value   Genes
  ------------ --------- ------------------------------------------------------------------------- ------- --------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Up           BP        GO:0007155-cell adhesion                                                  17      \<0.001   Col18A1, Tnfrsf12A, Pcdh10, Itga1, Nectin2, Bcam, Adgrg1, Igsf11, Vwf, Ambn, Dsg2, Cntn2, Lamc2, Emb, Cd24, Dpp4, Spp1
                         GO:0098609-cell-cell adhesion                                             12      0.003     Epcam, Cobll1, Ldha, Krt18, Lad1, Cgn, Baiap2L1, Ppl, Capg, Sptbn2, Perp, Eps8L1
                         GO:0031295-T cell costimulation                                           4       0.008     Ccl21, Ccl19, Cd24, Dpp4
                         GO:0001666-response to hypoxia                                            11      0.036     Muc1, Cd38, Ldha, Cldn3, Cryab, Arg2, Aldoc, P2Rx2, Cd24, Scnn1B, Dpp4
                         GO:0070555-response to interleukin-1                                      4       0.047     Cd38, Sphk1, Anxa1, Cited1
               CC        GO:0005913-cell-cell adherens junction                                    15      \<0.001   Cobll1, Ldha, Lad1, Baiap2L1, Anxa1, Nectin2, Krt18, Ezr, Sorbs1, Cgn, Ppl, Capg, Sptbn2, Dsc2, Eps8L1
                         GO:0005923-bicellular tight junction                                      9       0.002     Epcam, Cldn8, Cldn16, Pard6B, Igsf5, Cldn4, Cldn3, Cgn, Cldn10
                         GO:0031012-extracellular matrix                                           13      0.005     Sbspon, Col18A1, Coch, Clu, Mmrn1, Vwf, Plscr1, Sbsn, Dsp, Hspb1, Adamts1, Bmp7, Dpt
                         GO:0005578-proteinaceous extracellular matrix                             12      0.012     Coch, Gpc4, Vwf, Ambn, Adamts8, Lect1, Col6A6, Egfl6, Gpld1, Lamc2, Adamts1, Mepe
                         GO:0030054-cell junction                                                  15      0.034     Gabra1, Duox2, S100A14, Espn, Cadps, Gria2, Pkp2, Loc498368, Pkp4, Sptbn2, Smagp, Emb, Perp, Htr2B, Dpp4
               MF        GO:0098641-cadherin binding involved in cell-cell adhesion                13      \<0.001   Cobll1, Ldha, Lad1, Baiap2L1, Anxa1, Epcam, Krt18, Ezr, Cgn, Ppl, Capg, Sptbn2, Eps8L1
                         GO:0005518-collagen binding                                               6       0.005     Coch, Vwf, Itga1, Adgrg1, Dpp4, Pcolce2
                         GO:0042379-chemokine receptor binding                                     3       0.013     Ccl21, Ccl19, S100A14
                         GO:0031732-CCR7 chemokine receptor binding                                2       0.036     Ccl21, Ccl19
                         GO:0050839-cell adhesion molecule binding                                 5       0.039     Ezr, Dsg2, Dsp, Nectin2, Slc14A2
  Down         BP        GO:0007155-cell adhesion                                                  13      \<0.001   Nov, Lama1, Wisp2, Mybpc1, Fbln5, Comp, Tgfbi, Acan, Thbs2, Lrfn3, Plpp3, Emilin1, Farp2
                         GO:0010811-positive regulation of cell-substrate adhesion                 6       \<0.001   Egflam, Smoc1, Edil3, Vit, Ndnf, Emilin1
                         GO:0002224-toll-like receptor signaling pathway                           3       0.017     Tlr2, Tlr7, Tlr8
                         GO:0042346-positive regulation of NF-kappaB import into nucleus           3       0.017     Tlr2, Grem1, Tlr7
                         GO:0045356-positive regulation of interferon-alpha biosynthetic process   2       0.042     Tlr7, Tlr8
  Down         CC        GO:0005578-proteinaceous extracellular matrix                             26      \<0.001   Alpl, Fmod, Cthrc1, Wnt16, Mamdc2, Tgfb3, Mmp16, Vit, Ndnf, Emilin1, Cpz, Nov, Lama1, Wisp2, Wnt4, Egflam, Sfrp1, Comp, Smoc1, Fbln5, Tgfbi, Acan, Adamts12, Thbs2, Gpc1, Myoc
                         GO:0031012-extracellular matrix                                           21      \<0.001   Fmod, Aebp1, Tgfb3, Cpxm2, Mmp16, Edil3, Mmp14, Emilin1, Nov, Lama1, Sfrp1, Fbln5, Comp, Tgfbi, Acan, Cma1, Adamts12, Tpsab1, Pcsk6, Col8A2, Myoc
                         GO:0005615-extracellular space                                            43      \<0.001   Alpl, Fmod, Cthrc1, Rbp4, Wnt16, Aebp1, Prtg, Tgfb3, Grem1, Aldh3A1, Cpz, Rgd1310507, C1Qtnf5, Wisp2, Wnt4, Comp, Tgfbi, C1Qtnf2, Rgd1305645, Cpa3, Vnn1, Eno3, Sema3C, Ces1D, Pcsk6, Gpc1, Pcsk5, Myoc, Scg2, Vasn, Igf1, Cpxm2, Tcn2, Gas6, Clec11A, C8G, Lama1, Sfrp1, Fbln5, Cpxm1, Gdf10, Tpsab1, Bmp5
                         GO:0005576-extracellular region                                           23      \<0.001   Fcer1A, Fmod, Gas6, Ndnf, Clec11A, Mcpt1L1, C8G, Nov, Gzmm, Rgd1310507, Olfml3, C1Qtnf5, Hmcn1, Sfrp1, Comp, Fndc1, Npw, Pdgfrl, Cma1, Tpsb2, Prss23, Tpsab1, Pla2G2D
                         GO:0005614-interstitial matrix                                            4       \<0.001   Egflam, Mamdc2, Igf1, Vit
               MF        GO:0005178-integrin binding                                               9       \<0.001   Nov, Wisp2, Fbln5, Tgfbi, Igf1, Edil3, Mmp14, Plpp3, Thy1
                         GO:0008201-heparin binding                                                10      \<0.001   Nov, Fmod, Wisp2, Sfrp1, Comp, Pcsk6, Tpsb2, Thbs2, Pla2G2D, Ndnf
                         GO:0004181-metallocarboxypeptidase activity                               5       \<0.001   Aebp1, Cpxm1, Cpa3, Cpxm2, Cpz
                         GO:0004185-serine-type carboxypeptidase activity                          4       \<0.001   Aebp1, Cpxm1, Cpxm2, Cpz
                         GO:0005109-frizzled binding                                               5       \<0.001   Cthrc1, Wnt16, Wnt4, Sfrp1, Myoc

GO, gene ontology; BP, biological process; CC, cellular component; MF, molecular function.

###### 

Kyoto encyclopedia of genes and genomes pathway enrichment analysis for differentially expressed genes.

  Regulation   Term                                                       Count   P-value   Genes
  ------------ ---------------------------------------------------------- ------- --------- -----------------------------------------------------------------------------
  Up           rno04530:Tight junction                                    11      \<0.001   Cldn8, Cldn16, Pard6B, Igsf5, Cldn4, Cldn3, Cgn, Cldn10, Myh14, Myl9, Llgl2
               rno04966:Collecting duct acid secretion                    5       0.002     Atp6V1C2, Clcnkb, Atp6V1G3, Atp6V0A4, Car2
               rno04974:Protein digestion and absorption                  8       0.002     Col18A1, Kcnn4, Col9A3, Col6A6, Mme, Slc1A1, Kcnq1, Dpp4
               rno05412:Arrhythmogenic right ventricular cardiomyopathy   7       0.003     Dsg2, Pkp2, Itgb6, Itga1, Dsc2, Dsp, Cacna2D3
               rno04512:ECM-receptor interaction                          7       0.009     Vwf, Lamb3, Col6A6, Itgb6, Itga1, Lamc2, Spp1
               rno04670:Leukocyte transendothelial migration              7       0.034     Cldn8, Cldn16, Ezr, Cldn4, Cldn3, Cldn10, Myl9
  Down         rno05205:Proteoglycans in cancer                           7       0.008     Wnt16, Wnt4, Tlr2, Igf1, Fzd2, Gpc1, Twist1
               rno04916:Melanogenesis                                     5       0.011     Wnt16, Wnt4, Adcy8, Creb3L1, Fzd2
               rno05144:Malaria                                           4       0.015     Comp, Tlr2, Tgfb3, Thbs2
               rno04977:Vitamin digestion and absorption                  3       0.016     Slc5A6, Tcn2, Slc19A2
               rno05200:Pathways in cancer                                9       0.022     Lama1, Wnt16, Wnt4, Adcy8, Rasgrp2, Tgfb3, Skp2, Igf1, Fzd2
               rno05414:Dilated cardiomyopathy                            4       0.037     Sgcg, Adcy8, Tgfb3, Igf1
               rno04390:Hippo signaling pathway                           5       0.044     Wnt16, Wnt4, Tgfb3, Fzd2, Bmp5

###### 

Top 20 hub genes presented by topological property extracted from the protein-protein interaction network.

       Gene (value)                          
  ---- ------------------- ----------------- -----------------
  1    Ripk4 (47)          Ripk4 (11,351)    Ripk4 (28,108)
  2    Dpyd (31)           Dpyd (8,498)      Fos (15,278)
  3    Actg2 (31)          Actg2 (6,488)     Dpyd (10,661)
  4    Fos (25)            Aldh3a1 (6,317)   Agt (10,644)
  5    Pcsk5 (24)          Aldh1a3 (6,296)   Calb1 (8,620)
  6    Aldh1a1 (23)        Aldh1a1 (6,260)   Spp1 (7,876)
  7    Agt (23)            Pcsk5 (3,030)     Epcam (7,590)
  8    Aldh3a1 (22)        Gad1 (2,611)      Actg2 (6,459)
  9    Aldh1a3 (22)        Calb1 (2,598)     Myo5c (6,141)
  10   Calb1 (22)          Pcsk6 (2,557)     Eno3 (5,163)
  11   Pcsk6 (22)          Rasd1 (2,524)     Txndc5 (4,214)
  12   Myo5c (21)          Myo5c (2,491)     Cd24 (4,135)
  13   Gad1 (16)           Eno3 (2,170)      Krt8 (4,077)
  14   Eno3 (16)           Myo5b (2,134)     Aldh1a1 (3,840)
  15   Myo5b (16)          Rdh10 (1,939)     Pcsk5 (3,802)
  16   Rasd1 (15)          Bdh2 (1,906)      Pcsk6 (3,788)
  17   Itga1 (14)          Hpgd (1,906)      Itga1 (3,674)
  18   Igf1 (14)           Dhrs7c (1,906)    Gad1 (3,617)
  19   Itgb6 (14)          Fos (1,883)       Hspa1a (3,589)
  20   Hspa1a, Spp1 (13)   Cndp1 (1,832)     Itgb6 (3,555)

The number of interactions per node (protein).

Subgraph centrality, the weighted sum of all closed walks originating from each node.

Betweenness, the number of shortest paths that pass through each node.

###### 

Genes associated with immune response identified in rats and humans, obtained from a comparison with a study by Møller *et al* (16).

  Gene   logFC   P-value
  ------ ------- ---------
  Tlr7   −1.15   0.003
  Tlr2   −1.23   0.003
  Tlr8   −1.40   \<0.001
  Lpo    2.02    0.004
  Gzmm   −1.48   \<0.001
  Muc1   3.28    \<0.001

FC, fold change; Tlr, toll-like receptor; Lpo, lactoperoxidase; Gzmm, granzyme m; Muc, mucin.
